Answers are grounded in this paper and cite their sources.
To determine whether age-specific motor neuron disease (MND) incidence is better described by power-law age-dependence, compatible with multistep architecture, or by an exponential model. We analyzed curated Australian Motor Neuron Disease Registry data using age at symptom onset, clinical phenotype and Australian population denominators. The primary analysis modeled age-specific incidence across the 30-75-year range using 5-year age bands. Power-law and exponential Poisson models were compared using differences in Akaike Information Criterion (ΔAIC), with supplementary analyses across an expanded 20-90-year range and a restricted younger age range (<60 years). Across 2,556 patients in the primary analysis, the power-law model provided superior fit to the exponential model in the total cohort, with a ΔAIC of 60.06. The estimated power-law slope was 3.75, corresponding to 4.75 apparent steps. Power-law superiority was observed across clinical phenotypes, with the highest apparent step estimates in bulbar-onset ALS and flail arm syndrome, and the lowest in cervical-onset ALS and primary lateral sclerosis. Sensitivity analyses across expanded and restricted age ranges supported the primary findings. In the Australian MND Registry cohort, power-law age-dependence provided a better fit to observed age-specific incidence than the exponential alternative. These findings are compatible with a multistep model of MND pathogenesis but do not establish a fixed sequence of discrete pathogenic events.
No takes yet. Share an insight, caveat, or question.
Vucic et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: